Scynexis Competitors and Similar CompaniesClear all

Scynexis's competitors and similar companies include Petra Pharma, Lixte Biotechnology, NGM Biopharmaceuticals and BIAL.
Scynexis
Scynexis
Scynexis is engaged in drug discovery, development and manufacturing projects in various areas.
Petra Pharma
Petra Pharma
Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.
Lixte Biotechnology
Lixte Biotechnology
Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets.
NGM Biopharmaceuticals
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
BIAL
BIAL
BIAL is a pharmaceutical company that discovers, develops, and commercializes medicines.
Founding Date
Founding Date
2000
Founding Date
2016
Founding Date
2006
Founding Date
2007
Founding Date
1924
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Jersey City, US HQ
Locations
New York, US HQ
Locations
East Setauket, US HQ
Pasadena, US
Locations
South San Francisco, US HQ
Locations
Madrid, ES HQ
Abidjan, CI
Bremen, DE
Mörfelden Walldorf, DE
Milano, IT
Panamá, PA
Windsor, GB
see more
Employees
Employees
3636% decrease
Employees
20
Employees
3
Employees
18622% increase
Employees
941
Valuation ($)
Valuation ($)
53 m
Valuation ($)
N/A
Valuation ($)
2.9 m
Valuation ($)
128.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$20.6m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$4.4m (FY, 2023)
Revenue (est.)
N/A
Net income
Net income
($8.6m) (FY, 2025)
Net income
N/A
Net income
($6m) (FY, 2025)
Net income
($142.4m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 11.5m
Total funding raised
$ 48m
Total funding raised
$ 1.8m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Petra Pharma
HQ
New York, US

Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.

View company
Lixte Biotechnology
HQ
East Setauket, US
Employees
3

Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets.

View company
NGM Biopharmaceuticals
HQ
South San Francisco, US
Employees
186↑ 22% increase

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

View company
BIAL
HQ
Madrid, ES
Employees
941

BIAL is a pharmaceutical company that discovers, develops, and commercializes medicines.

View company